ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,960, issued on April 14, was assigned to AB Enzymes Finland Oy (Rajamaki, Finland).
"Xylanase variants" was invented by Marja Paloheimo (Rajamaki, Finland), Kari Juntunen (Rajamaki, Finland), Ossi Turunen (Nummela, Finland), Pihla Ahola (Rajamaki, Finland), Pasi Taipalus (Rajamaki, Finland), Eugen Muller (Darmstadt, Germany), Jukka Savolainen (Tampere, Finland), Kim Langfelder (Darmstadt, Germany) and Terhi Puranen (Rajamaki, Finland).
According to the abstract* released by the U.S. Patent & Trademark Office: "A variant polypeptide of xylanase, and a fusion protein and an enzyme composition comprising the variant polypeptide, a recombinant host cell for production of the variant...